Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.

Journal Information

Full Title: Antimicrob Agents Chemother

Abbreviation: Antimicrob Agents Chemother

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability all raw sequencing data are available in the national center for biotechnology information (ncbi) short read archive (sra) under bioproject prjna1035781 (accession numbers srr26669148 to srr26669387 ). data availability all raw sequencing data are available in the national center for biotechnology information (ncbi) short read archive (sra) under bioproject prjna1035781"

Code Sharing
Evidence found in paper:

"J.S., J.M.G., N.M., J.H., B.H., K.C.K., P.M., and S.L.G. are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA."

Evidence found in paper:

"This work was supported by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025